Home › Funds › Aristotle Capital Boston, LLC › CNS

Aristotle Capital Boston, LLC position in CNS

COHEN & STEERS INC · Financials

Aristotle Capital Boston, LLC reported holding 140,341 shares of CNS (COHEN & STEERS INC) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 0.91% of its reported portfolio and ranking #47 among its reported holdings. Aristotle Capital Boston, LLC has disclosed CNS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)140.34K sh
Reported value held$10.26M
Portfolio Weight0.91%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Aristotle Capital Boston, LLC's CNS position evolved

Aristotle Capital Boston, LLC first disclosed a stake in CNS in Q3 2023 at 209,156 shares (US$13.1M). The position peaked in Q4 2023 at 181,357 shares, worth US$13.7M. Across 13 filings, Aristotle Capital Boston, LLC increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 140,341 shares valued at US$10.3M — a reduction of -32,921 shares quarter over quarter.. Notable position changes include a 56% trim in Q4 2024 (shares fell 13% over the following quarter), a 34% trim in Q1 2025 (shares fell 6% over the following quarter), a 683% increase in Q4 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 209.16K $13.11M New
Q4 2023 181.36K $13.73M Reduce
Q1 2024 166.42K $12.80M Reduce
Q2 2024 132.18K $9.59M Reduce
Q3 2024 102.44K $9.83M Reduce
Q4 2024 45.40K $4.19M Reduce
Q1 2025 30.15K $2.42M Reduce
Q2 2025 26.98K $2.03M Reduce
Q3 2025 25.64K $1.68M Reduce
Q4 2025 200.70K $12.60M Add
Q1 2026 191.16K $11.97M Reduce
Q2 2026 173.26K $13.19M Reduce
Q3 2026 140.34K $10.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNS and 13F data

CNS (COHEN & STEERS INC) is a Financials company. 34 other funds we track also report a position in CNS — the largest reported positions include Copeland Capital Management, LLC (US$54.6M), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (US$21.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNS

All CNS fund holders →

FAQ

How long has Aristotle Capital Boston, LLC held CNS?

Aristotle Capital Boston, LLC has disclosed CNS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aristotle Capital Boston, LLC's current position in CNS?

As of Q3 2026, Aristotle Capital Boston, LLC holds 140.34K shares of CNS (COHEN & STEERS INC), valued at $10.26M, representing 0.91% of its reported portfolio and ranking #47.

Has Aristotle Capital Boston, LLC been buying or selling CNS?

In the latest 13F filing (Q3 2026), Aristotle Capital Boston, LLC reduced its position in CNS. The position peaked in Q4 2023 at 181.36K shares.

Which other funds hold CNS?

Other major institutional holders of CNS include Copeland Capital Management, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.